1. Home
  2. XERS vs IMKTA Comparison

XERS vs IMKTA Comparison

Compare XERS & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XERS

Xeris Biopharma Holdings Inc.

N/A

Current Price

$10.51

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

N/A

Current Price

$85.57

Market Cap

1.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
XERS
IMKTA
Founded
2005
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
XERS
IMKTA
Price
$10.51
$85.57
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $12.86
N/A
AVG Volume (30 Days)
★ 2.3M
82.6K
Earning Date
11-05-2026
11-25-2026
Dividend Yield
N/A
★ 0.77%
EPS Growth
★ 100.00
N/A
EPS
N/A
★ N/A
Revenue
$49,590,000.00
★ $5,334,032,609.00
Revenue This Year
$32.91
N/A
Revenue Next Year
$23.75
N/A
P/E Ratio
★ N/A
$15.91
Revenue Growth
★ 142.67
N/A
52 Week Low
$5.25
$67.17
52 Week High
$10.35
$95.62

Technical Indicators

Market Signals
Indicator
XERS
IMKTA
Relative Strength Index (RSI) 69.93 55.03
Support Level $7.15 $82.64
Resistance Level N/A $90.01
Average True Range (ATR) 0.52 1.76
MACD 0.13 0.23
Stochastic Oscillator 99.03 61.22

Price Performance

Historical Comparison
XERS
IMKTA

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: